ReviewMolecular biomedicine2026

Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities.

Mingkang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.